aiqbench analysis
This collaboration establishes a significant benchmark for applying large-scale multi-agent systems to solve high-complexity biomedical problems by processing experimental data and literature in parallel. The initiative moves beyond simple text generation to focus on verifiable hypothesis generation, marking a concrete step toward autonomous AI agents driving scientific discovery pipelines.
PerturbAI Partners with OpenAI to Develop AI Reasoning Agents, Accelerating Biomedical Research
On October 21, biotechnology company PerturbAI announced a collaboration with OpenAI and the Scripps Research Institute to develop an AI reasoning framework. The initiative leverages thousands of agents to analyze biological experiment data in parallel, retrieve scientific literature, and propose verifiable research hypotheses. The partnership will further explore new drug targets.
Read the full article at 36KrRelated coverage
Aligning LLMs with Biomedical Knowledge using Balanced Fine-Tuning
arXiv · Oct 7, 2026
Towards World Models in Biomedical Research
arXiv · Aug 27, 2026
Towards World Models in Biomedical Research
arXiv · Jun 6, 2026

How a medical database developed at MIT evolved into a global standard of data-sharing
MIT News · Jul 29, 2026